Cargando…

Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis

PURPOSE: To compare the efficacy and safety of infliximab with that of adalimumab in the treatment of non-infectious uveitis (NIU). METHODS: We searched for relevant studies in the PubMed, Embase, ClinicalTrials.gov, Cochrane Library databases, Grey Matters, Grey Literature Report, OpenGrey, China N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Weishai, Bai, Dan, Kou, Lieling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226205/ https://www.ncbi.nlm.nih.gov/pubmed/37248486 http://dx.doi.org/10.1186/s12886-023-02987-1

Ejemplares similares

Progress in central retinal artery occlusion: a narrative review
por: Liu, Weishai, et al.
Publicado: (2023)

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review
por: Ming, Shuai, et al.
Publicado: (2018)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
por: Yang, Hua-Hua, et al.
Publicado: (2022)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

Outcomes of treatment with sirolimus for non-infectious uveitis: a meta-analysis and systematic review
por: Cabahug, Vicente Lorenzo O, et al.
Publicado: (2019)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Comparing adalimumab and infliximab in the prevention of postoperative recurrence of Crohn’s disease: a systematic review and meta-analysis
por: Gangwani, Manesh Kumar, et al.
Publicado: (2023)

Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis
por: Savelkoul, Edo H J, et al.
Publicado: (2022)

Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis
por: Miraldi Utz, Virginia, et al.
Publicado: (2019)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
por: Henry, Alistair I, et al.
Publicado: (2011)

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
por: Kawalec, Paweł, et al.
Publicado: (2016)

Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Biao, et al.
Publicado: (2021)

Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
por: Kawalec, Paweł, et al.
Publicado: (2013)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis
por: Hebeisen, Monika, et al.
Publicado: (2019)

Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014)

Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis
por: Wang, Han, et al.
Publicado: (2022)

Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy
por: Pirani, Vittorio, et al.
Publicado: (2020)

Infliximab in the treatment of refractory uveitis. Does dose really matter?
por: Sukumaran, MD Sukesh, et al.
Publicado: (2011)

Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
por: Lee, Yong Il, et al.
Publicado: (2021)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review
por: Joltikov, Katherine A., et al.
Publicado: (2021)

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
por: García-De-Vicuña, Carmen, et al.
Publicado: (2013)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
por: Reinisch, Walter, et al.
Publicado: (2020)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab
por: Ohshima, Yuichiro, et al.
Publicado: (2013)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
por: Im, Jong Pil
Publicado: (2017)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Adalimumab/infliximab: Lower serologic response: 6 case reports
Publicado: (2022)

Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis
por: Kouwenberg, Carlyn V., et al.
Publicado: (2021)

High Dose Infliximab in the Treatment of Refractory Uveitis: Does Dose Matter?
por: Sukumaran, Sukesh, et al.
Publicado: (2012)

mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol
por: Blair, Joshua, et al.
Publicado: (2018)

Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
por: Valdes, Lianna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jqd2qvn0bvr06so1pitj94cit3